Complement Inhibitors in Age-Related Macular Degeneration: A Potential Therapeutic Option
Age-related macular degeneration (AMD) is a multifactorial disease, which can culminate in irreversible vision loss and blindness in elderly. Nowadays, there is a big gap between dry AMD and wet AMD on treatment. Accounting for nearly 90% of AMD, dry AMD still lacks effective treatment. Numerous gen...
Saved in:
| Main Authors: | Shuqi Qin, Ning Dong, Ming Yang, Jialin Wang, Xue Feng, Yanling Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2021/9945725 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Relationship between Complements and Age-Related Macular Degeneration and Its Pathogenesis
by: Liyuan Chu, et al.
Published: (2024-01-01) -
Zinc supplementation inhibits complement activation in age-related macular degeneration.
by: Dzenita Smailhodzic, et al.
Published: (2014-01-01) -
Efficacy and safety of complement inhibitors in patients with geographic atrophy associated with age-related macular degeneration: a network meta-analysis of randomized controlled trials
by: Huan Wang, et al.
Published: (2024-11-01) -
Ferroptosis: An Energetic Villain of Age-Related Macular Degeneration
by: Na Zhao, et al.
Published: (2025-04-01) -
Optimizing the use of angiogenesis inhibitor in neovascular age-related macular degeneration
by: F. A. Bakhritdinova, et al.
Published: (2018-10-01)